$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
吡托布鲁替尼的用法用量
2025-10-19 11:44:20
Check Details
吡托布鲁替尼(pirtobrutinib)FDA获批,用于治疗套细胞淋巴瘤和慢性淋巴细胞白血病或小淋巴细胞淋巴瘤
2025-10-19 11:44:20
Check Details
吡托布鲁替尼(pirtobrutinib)用法用量:推荐剂量,剂量调整
2025-10-19 11:44:20
Check Details
吡托布鲁替尼(pirtobrutinib)的副作用和常见不良反应 xa0
2025-10-19 11:44:20
Check Details
吡托布鲁替尼(pirtobrutinib)详细说明书
2025-10-19 11:44:20
Check Details
吡托布鲁替尼(pirtobrutinib)中文说明书:适应症、用法用量、不良反应、注意事项
2025-10-19 11:44:20
Check Details
伐美妥司他的适应症
2025-10-19 11:44:20
Check Details
伐美妥司他的副作用如何缓解
2025-10-19 11:44:20
Check Details
普乐沙福国内价格是多少
2025-10-19 11:44:20
Check Details
普乐沙福的副作用如何缓解
2025-10-19 11:44:20
Check Details
普乐沙福的副作用与注意事项
2025-10-19 11:44:20
Check Details
普乐沙福的用药指南
2025-10-19 11:44:20
Check Details
1
2
...
1281
1282
1283
1284
1285
1286
1287
...
4150
4151
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Brigatinib Medication Case Study: Three-Year Treatment Record and Experience Sharing of ALK-Positive Lung Cancer Patient
2
What is Brigatinib (Alunbrig)? Complete Guide to ALK-Positive Lung Cancer Targeted Therapy & Medication Guidelines
3
Repotrectinib (Augtyro) Complete Medication Guide 2026: Import Original Drug Price, Eligible Patients & Full Usage Information
4
Ceritinib Capsule Storage Conditions & Expiration Guide: Room Temperature Storage, No Refrigeration Needed
5
Selumetinib for NF1 Treatment: Complete Guide to Targeted Therapy for Type 1 Neurofibromatosis
6
Alectinib for ALK-Positive Lung Cancer: Efficacy, Side Effects & Clinical Outlook
7
Which Generation TKI Is Repotrectinib? Professional Analysis of Next-Gen ROS1 Inhibitor Classification and Clinical Features
8
Dietary Guide During Goserelin Treatment: Scientific Nutrition Management to Alleviate Side Effects and Improve Quality of Life.
9
CYP26A1 Gene Emerges as New Target for Colorectal Cancer Treatment! Folate Metabolism Research Brings Hope for Immunotherapy.
10
Precision Breakthrough: Inavolisib Redefines Survival in PIK3CA-Mutant Breast Cancer
11
Optimal Regorafenib (Stivarga) Administration Guide: Low-Fat Diet, Fixed Timing, and Dose Escalation Strategies
12
Guidelines for the timing, method, and precautions of taking Erlotinib (Trokai).